National Medicines Policy Review to begin in August 2021
Page last updated: 24 June 2021
The Review of the National Medicines Policy (NMP) (the Review) will begin in August 2021.
Published in 2000, Australia’s National Medicines Policy (NMP) provides the policy framework for the delivery of four objectives. The four central objectives include:
- timely access to the medicines that Australians need, at a cost individuals and the community can afford;
- medicines meeting appropriate standards of quality, safety and efficacy;
- quality use of medicines; and
- maintaining a responsible and viable medicines industry
A stakeholder consultation process involving a call for public submissions will support the Review. The Review’s findings will contribute to ensuring Australia’s NMP remains fit for purpose and relevant to the medicines landscape, now and into the future.
Professor Michael Kidd AM will Chair the Review Committee. Professor Kidd is:
- Deputy Chief Medical Officer and Principal Medical Adviser with the Commonwealth Department of Health
- The foundation Professor of Primary Care Reform at The Australian National University.